Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose norepinephrine with goal-directed fluid therapy in thoracic surgery
ChiCTR2200064081Phase 4Completed
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of norepinephrine in postoperative respiratory complications (PRC) and anoxemia (3 arms), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoint: Postoperative pulmonary complications. Started Sep 2022; status: completed.
02
Drugs
norepinephrine
03
Conditions
postoperative respiratory complications (PRC)anoxemia
Beyond the preview
Go deeper on ChiCTR2200064081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064081.